tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

LGVN Stock Latest News

Longeveron management to meet with Roth MKM
The FlyLongeveron management to meet with Roth MKM
4d ago
LGVN
Buy Rating for Longeveron: ELPIS II Trial Progress and Financial Stability Highlighted
PremiumRatings
Buy Rating for Longeveron: ELPIS II Trial Progress and Financial Stability Highlighted
27d ago
LGVN
Longeveron: Strategic Advancements and Promising Developments Drive Buy Rating
PremiumRatings
Longeveron: Strategic Advancements and Promising Developments Drive Buy Rating
1M ago
LGVN
Longeveron Reports Q1 2025 Progress and Financials
PremiumCompany Announcements
Longeveron Reports Q1 2025 Progress and Financials
1M ago
LGVN
Longeveron Re-approves Cash-to-Equity Program Strategy
PremiumCompany Announcements
Longeveron Re-approves Cash-to-Equity Program Strategy
1M ago
8K
LGVN
Longeveron files $70M mixed securities shelf
PremiumThe FlyLongeveron files $70M mixed securities shelf
3M ago
LGVN
Longeveron’s Promising Alzheimer’s Program: Buy Rating Backed by FDA Alignment and Strategic Advancements
Premium
Ratings
Longeveron’s Promising Alzheimer’s Program: Buy Rating Backed by FDA Alignment and Strategic Advancements
3M ago
LGVN
Longeveron’s Promising Alzheimer’s Treatment and Favorable Regulatory Developments Drive Buy Rating
Premium
Ratings
Longeveron’s Promising Alzheimer’s Treatment and Favorable Regulatory Developments Drive Buy Rating
3M ago
LGVN
Longeveron announces outcome of Type B meeting with FDA on Lomecel-B
PremiumThe Fly
Longeveron announces outcome of Type B meeting with FDA on Lomecel-B
3M ago
LGVN
Longeveron announces publication of results of Phase 2a trial of Lomecel-B
PremiumThe Fly
Longeveron announces publication of results of Phase 2a trial of Lomecel-B
3M ago
LGVN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ADMA
ALDX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ALDX
ANRO
Longeveron’s Clinical Advancements and Strategic Positioning Earn a Buy Rating
PremiumRatingsLongeveron’s Clinical Advancements and Strategic Positioning Earn a Buy Rating
3M ago
LGVN
Longeveron Inc. Earnings Call: Growth and Challenges
Premium
Company Announcements
Longeveron Inc. Earnings Call: Growth and Challenges
3M ago
LGVN
Promising Outlook for Longeveron: ELPIS II Trial Progress and Financial Strength Highlighted
Premium
Ratings
Promising Outlook for Longeveron: ELPIS II Trial Progress and Financial Strength Highlighted
3M ago
LGVN
Longeveron Inc. Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Longeveron Inc. Reports Strong 2024 Financial Growth
4M ago
LGVN
Longeveron reports Q4 revenue $700,000, consensus $637,500
PremiumThe Fly
Longeveron reports Q4 revenue $700,000, consensus $637,500
4M ago
LGVN
LGVN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LGVN Earnings this Week: How Will it Perform?
4M ago
LGVN
Longeveron management to meet with Maxim
PremiumThe Fly
Longeveron management to meet with Maxim
4M ago
LGVN
Longeveron’s Lomecel receives WHO non-proprietary name approval as laromestroce
PremiumThe FlyLongeveron’s Lomecel receives WHO non-proprietary name approval as laromestroce
4M ago
LGVN
Longeveron Board Member Neil Hare Resigns
Premium
Company Announcements
Longeveron Board Member Neil Hare Resigns
5M ago
8K
LGVN
Longeveron initiated with a Buy at Roth MKM
Premium
The Fly
Longeveron initiated with a Buy at Roth MKM
6M ago
LGVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >